References:
- Rychik J, Tian Z. Fetal Cardiovascular Imaging E-Book: Expert Consult
Premium. Elsevier Health Sciences; 2011. 529 p.
- Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo Júnior E.
Fetal cardiac arrhythmias: Current evidence. Ann Pediatr Cardiol.
2018;11(2):148-163. doi:10.4103/apc.APC_134_17
- Kleinman CS, Nehgme R, Copel JA. Fetal cardiac arrhythmias: diagnosis
and therapy. In: Creasy RK, Resnik R (Eds.), Maternal-Fetal Medicine
(4th ed). Saunders; 1999. p. 301-318.
- Caruso E, Farruggio S, Agati S, Di Mambro C. Fetal Bradyarrhythmias:
Etiopathogenesis, Diagnosis and Treatment: Between Literature Review
and Experience of a Tertiary Center. Congenital Heart Disease .
2021;16(4):309-331. doi:https://doi.org/10.32604/chd.2021.015470
- Yagel S, Silverman NH, Gembruch U. Fetal cardiology: embryology,
genetics, physiology, echocardiographic evaluation, diagnosis, and
perinatal management of cardiac diseases. Third edition. CRC Press.
2019. doi: 10.1201/9780429461118.
- Kleinman CS, Hobbins JC, Jaffe CC, Lynch DC, Talner NS.
Echocardiographic studies of the human fetus: prenatal diagnosis of
congenital heart disease and cardiac dysrhythmias. Pediatrics.
1980;65(6):1059-1067.
- Strasburger JF, Wakai RT. Fetal cardiac arrhythmia detection and in
utero therapy. Nat Rev Cardiol. 2010;7(5):277-290.
doi:10.1038/nrcardio.2010.32
- Yuan SM, Xu ZY. Fetal arrhythmias: prenatal evaluation and
intrauterine therapeutics. Ital J Pediatr. 2020;46(1):21. Published
2020 Feb 12. doi:10.1186/s13052-020-0785-9
- Araujo J EA, Bravo-Valenzuela NJM, Peixoto AB, editors. Perinatal
cardiology Part 1. Bentham Science Publishers; 2020.
- Chih WL, Olisova K, Tung YH, Huang YL, Chang TY. Fetal arrhythmias
case series: Experiences from a fetal screening center in Taiwan.
Taiwan J Obstet Gynecol. 2023;62(3):480-484.
doi:10.1016/j.tjog.2023.01.007
- Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal
outcome of fetal complete atrioventricular block: a multicenter
experience. J Am Coll Cardiol. 1991;17(6):1360-1366.
doi:10.1016/s0735-1097(10)80148-2
- Maeno Y, Himeno W, Saito A, et al. Clinical course of fetal congenital
atrioventricular block in the Japanese population: a multicentre
experience. Heart. 2005;91(8):1075-1079. doi:10.1136/hrt.2003.033407
- Lopes LM, Tavares GM, Damiano AP, et al. Perinatal outcome of fetal
atrioventricular block: one-hundred-sixteen cases from a single
institution [published correction appears in Circulation. 2008 Oct
14;118(16): e671]. Circulation. 2008;118(12):1268-1275.
doi:10.1161/CIRCULATIONAHA.107.735118
- Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT.
Electrophysiological characteristics of fetal atrioventricular block.
J Am Coll Cardiol. 2008;51(1):77-84. doi:10.1016/j.jacc.2007.06.060
- Bravo-Valenzuela NJ, Araujo Júnior E. Inappropriate fetal sinus
tachycardia at 9 weeks of gestation. Ann Pediatr Cardiol.
2022;15(4):399-403. doi:10.4103/apc.apc_130_21
- Ciardulli A, D’Antonio F, Magro-Malosso ER, et al. Maternal steroid
therapy for fetuses with second-degree immune-mediated congenital
atrioventricular block: a systematic review and meta-analysis. Acta
Obstet Gynecol Scand. 2018;97(7):787-794. doi:10.1111/aogs.13338
- Trucco SM, Jaeggi E, Cuneo B, et al. Use of intravenous gamma globulin
and corticosteroids in the treatment of maternal autoantibody-mediated
cardiomyopathy. J Am Coll Cardiol. 2011;57(6):715-723.
doi:10.1016/j.jacc.2010.09.044
- Cuneo BF. Fetal Bradycardia. In: Yagel S, Silverman NH, Gembruch U,
editors. Fetal Cardiology. 3rd ed. Taylor and Francis, LLC; Boca
Raton, FL, USA: 2019.
- Bergmans MG, Jonker GJ, Kock HC. Fetal supraventricular tachycardia.
Review of the literature. Obstet Gynecol Surv. 1985;40(2):61-68.
doi:10.1097/00006254-198502000-00002
- Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger
LK. Transplacental fetal treatment improves the outcome of prenatally
diagnosed complete atrioventricular block without structural heart
disease. Circulation. 2004;110(12):1542-1548.
doi:10.1161/01.CIR.0000142046.58632.3A
- Friedman DM, Kim MY, Copel JA, Llanos C, Davis C, Buyon JP.
Prospective evaluation of fetuses with autoimmune-associated
congenital heart block followed in the PR Interval and Dexamethasone
Evaluation (PRIDE) Study. Am J Cardiol. 2009;103(8):1102-1106.
doi:10.1016/j.amjcard.2008.12.027
- Friedman DM, Llanos C, Izmirly PM, et al. Evaluation of fetuses in a
study of intravenous immunoglobulin as preventive therapy for
congenital heart block: Results of a multicenter, prospective,
open-label clinical trial. Arthritis Rheum. 2010;62(4):1138-1146.
doi:10.1002/art.27308
- Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in
the treatment of fetal tachycardias. Br Heart J. 1991;65(1):46-48.
doi:10.1136/hrt.65.1.46
- Jennifer NA, Edward KR. Diagnosis and Treatment of Fetal
Tachyarrhythmias. US Cardiology. 2006;3(2):1-5.
- Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U.
Review of diagnosis, treatment, and outcome of fetal atrial flutter
compared with supraventricular tachycardia. Heart. 2003;89(8):913-917.
doi:10.1136/heart.89.8.913
- Singh GK. Management of Fetal Tachyarrhythmias. Curr Treat Options
Cardiovasc Med. 2004;6(5):399-406. doi:10.1007/s11936-004-0023-6
- Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of
127 consecutive cases. Heart. 1998;79(6):576-581.
- Simpson LL. Fetal supraventricular tachycardias: diagnosis and
management. Semin Perinatol. 2000;24(5):360-372.
doi:10.1053/sper.2000.1654
- Cuneo BF, Strasburger JF. Management strategy for fetal tachycardia.
Obstet Gynecol. 2000;96(4):575-581. doi:10.1016/s0029-7844(00)00996-0
- Ebenroth ES, Cordes TM, Darragh RK. Second-line treatment of fetal
supraventricular tachycardia using flecainide acetate. Pediatr
Cardiol. 2001;22(6):483-487. doi:10.1007/s002460010279
- Maeno Y, Hirose A, Kanbe T, Hori D. Fetal arrhythmia: prenatal
diagnosis and perinatal management. J Obstet Gynaecol Res.
2009;35(4):623-629. doi:10.1111/j.1447-0756.2009.01080.x
- Hornberger LK, Sahn DJ. Rhythm abnormalities of the fetus. Heart.
2007;93(10):1294-1300. doi:10.1136/hrt.2005.069369
- Oudijk MA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of
fetal dysrhythmias. Circulation. 2000;101(23):2721-2726.
doi:10.1161/01.cir.101.23.2721
- Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the
intrauterine treatment of fetal supraventricular tachycardia.
Ultrasound Obstet Gynecol. 2002;19(2):158-164.
doi:10.1046/j.0960-7692.2001.00562.x
- Broom E, Thomas JT, Petersen S, et al. Management of Fetal
Supraventricular Tachycardia: Case Series from a Tertiary Perinatal
Cardiac Center. Fetal Diagn Ther. 2021;48(11-12):794-800.
doi:10.1159/000519911
- Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the
intrauterine treatment of fetal supraventricular tachycardia.
Ultrasound Obstet Gynecol. 2002;19(2):158-164.
doi:10.1046/j.0960-7692.2001.00562.x
- Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo Júnior E.
Fetal cardiac arrhythmias: Current evidence [published correction
appears in Ann Pediatr Cardiol. 2018 Sep-Dec;11(3):332]. Ann Pediatr
Cardiol. 2018;11(2):148-163. doi:10.4103/apc.APC_134_17
- Strasburger JF. Prenatal diagnosis of fetal arrhythmias. Clin
Perinatol. 2005;32(4):891-viii. doi:10.1016/j.clp.2005.09.011
- Cuneo BF, Strasburger JF, Niksch A, Ovadia M, Wakai RT. An expanded
phenotype of maternal SSA/SSB antibody-associated fetal cardiac
disease. J Matern Fetal Neonatal Med. 2009;22(3):233-238.
doi:10.1080/14767050802488220